Rita Golfieri
Overview
Explore the profile of Rita Golfieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
294
Citations
4514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mottola M, Golfieri R, Bevilacqua A
Sensors (Basel)
. 2024 Feb;
24(4).
PMID: 38400314
Based on the well-known role of peritumour characterization in cancer imaging to improve the early diagnosis and timeliness of clinical decisions, this study innovated a state-of-the-art approach for peritumour analysis,...
2.
Reimer P, Vilgrain V, Arnold D, Balli T, Golfieri R, Loffroy R, et al.
Cardiovasc Intervent Radiol
. 2024 Feb;
47(3):310-324.
PMID: 38321223
Purpose: Transarterial radioembolization (TARE) with Yttrium-90 resin microspheres is a treatment option for patients with intrahepatic cholangiocarcinoma (ICC). However, optimising the timing of TARE in relation to systemic therapies and...
3.
Cabibbo G, Daniele B, Borzio M, Casadei-Gardini A, Cillo U, Colli A, et al.
Dig Liver Dis
. 2023 Dec;
56(3):394-405.
PMID: 38052656
Worldwide, hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death. The remarkable improvements in treating HCC achieved in the last years have increased the complexity of its...
4.
Cabibbo G, Daniele B, Borzio M, Casadei-Gardini A, Cillo U, Colli A, et al.
Dig Liver Dis
. 2023 Nov;
56(2):223-234.
PMID: 38030455
Worldwide, hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death. The remarkable improvements in treating HCC achieved in the last years have increased the complexity of HCC...
5.
Carlini G, Gaudiano C, Golfieri R, Curti N, Biondi R, Bianchi L, et al.
J Pers Med
. 2023 Mar;
13(3).
PMID: 36983660
Background: Benign renal tumors, such as renal oncocytoma (RO), can be erroneously diagnosed as malignant renal cell carcinomas (RCC), because of their similar imaging features. Computer-aided systems leveraging radiomic features...
6.
Zavatta G, Vicennati V, Altieri P, Tucci L, Colombin G, Coscia K, et al.
Eur J Endocrinol
. 2023 Mar;
188(4):343-352.
PMID: 36952249
Objective: Mild autonomous cortisol secretion (MACS) has been associated with a higher prevalence of osteoporosis, although most data rely on single-center studies with limited sample size. We aimed to assess...
7.
Mosconi C, Cacioppa L, Cappelli A, Gramenzi A, Vara G, Modestino F, et al.
Technol Cancer Res Treat
. 2023 Mar;
22:15330338231155690.
PMID: 36927302
Background: Intrahepatic cholangiocarcinoma (ICC) is the second most common primitive liver cancer and is rising in incidence worldwide. Given its low survival and resectability rates, locoregional therapies such as Yttrium-90...
8.
Cuicchi D, Mottola M, Castellucci P, Bevilacqua A, Cattabriga A, Cocozza M, et al.
J Clin Med
. 2023 Mar;
12(5).
PMID: 36902845
Locally Recurrent Rectal Cancer (LRRC) remains a major clinical concern; it rapidly invades pelvic organs and nerve roots, causing severe symptoms. Curative-intent salvage therapy offers the only potential for cure...
9.
Gaudiano C, Braccischi L, Taninokuchi Tomassoni M, Paccapelo A, Bianchi L, Corcioni B, et al.
Front Oncol
. 2023 Mar;
13:1082564.
PMID: 36890814
Background: To evaluate multiparametric magnetic resonance imaging (mpMRI) parameters, such as TransPA (transverse prostate maximum sectional area), TransCGA (transverse central gland sectional area), TransPZA (transverse peripheral zone sectional area), and...
10.
Mosconi C, ORourke J, Kloeckner R, Sturm L, Golfieri R, Celsa C, et al.
Cardiovasc Intervent Radiol
. 2023 Feb;
46(4):449-459.
PMID: 36849836
Purpose: Textbook Outcome (TO) is inclusive of quality indicators and it not been provided for trans-arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). Materials And Methods: Data on treatment-naïve HCC patients...